SCHEMBL2838997

SCHEMBL2838997

NC(c1ccc(C(F)(F)F)cc1)C(O)c1ccc(-c2cccnc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
KIF11 P52732 3/20 0.47
S1PR1 P21453 1/20 0.46
NPY5R Q15761 1/20 0.46
KDR P35968 3/20 0.45
DGAT1 O75907 1/20 0.45
KCNH2 Q12809 1/20 0.45
KCNA5 P22460 1/20 0.42
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 2/20 0.41
EGFR P00533 1/20 0.41
FGFR1 P11362 1/20 0.41
FFAR1 O14842 1/20 0.41
EPHX2 P34913 1/20 0.41
CYP2A6 P11509 2/20 0.40
NTRK1 P04629 1/20 0.40
CYP17A1 P05093 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7809713 1.00 NPC1 (0.49) NPC1KIF11S1PR1NPY5RKDR
SCHEMBL2839284 0.82 CYP19A1 (0.46) NPC1NPY5RMKNK1MKNK2CYP2A6
SCHEMBL7803951 0.82 CYP19A1 (0.46) NPC1NPY5RMKNK1MKNK2CYP2A6
SCHEMBL2838289 0.82 CYP11B2 (0.43) KIF11KDRMKNK1MKNK2
SCHEMBL7809794 0.82 CYP11B2 (0.43) KIF11KDRMKNK1MKNK2
SCHEMBL6552315 0.81 NPC1 (0.68) NPC1KIF11S1PR1NPY5RKDR
SCHEMBL22778182 0.81 NPC1 (0.68) NPC1KIF11S1PR1NPY5RKDR
SCHEMBL29468037 0.81 NPC1 (0.68) NPC1KIF11S1PR1NPY5RKDR
Hydrochloric Acid SCHEMBL2838936 0.81 CYP19A1 (0.45) NPC1NPY5RMKNK1MKNK2CYP2A6
SCHEMBL30620725 0.80 CES2 (0.47) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398558-A1 AMINE OR AMINO ALCOHOLS AS GLYT1 INHIBITORS F. Hoffmann-La Roche AG (CH) 2011-12-28 EP claimed
WO-2010094659-A1 AMINE OR AMINO ALCOHOLS AS GLYT1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-08-26 WO claimed
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-08-19 US claimed
US-8367838-B2 Amines or amino alcohols as GLYT1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-02-05 US disclosed
US-20120232033-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS KOLCZEWSKI SABINE (DE) 2012-09-13 US disclosed
EP-2398558-A1 AMINE OR AMINO ALCOHOLS AS GLYT1 INHIBITORS F. Hoffmann-La Roche AG (CH) 2011-12-28 EP disclosed
WO-2010094659-A1 AMINE OR AMINO ALCOHOLS AS GLYT1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2010-08-26 WO disclosed
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS HOFFMANN-LA ROCHE, INC. 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232033-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS GFPT1, CEPT1, SLC18A2 NPC1 182/4885KIF11 1930/4885S1PR1 1528/4885
US-20100210592-A1 AMINES OR AMINO ALCOHOLS AS GLYT1 INHIBITORS GFPT1, CEPT1, SLC18A2 NPC1 182/4885KIF11 1930/4885S1PR1 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.